Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-{alpha}]quinoline in colon cancer cells depending on their p53 status
Publication status
publishedExternal links
Journal / series
Molecular Cancer TherapeuticsVolume
Pages / Article No.
Publisher
American Association for Cancer ResearchOrganisational unit
02207 - Functional Genomics Center Zurich / Functional Genomics Center Zurich
08828 - Schlapbach, Ralph (Tit.-Prof.)
Notes
Received 14 November 2007. revised 28 March 2008. accepted 30 March 2008.More
Show all metadata
ETH Bibliography
yes
Altmetrics